Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-10-10)Premium Content

Allergan Inc (AGN)

2014-12-20@21:27:52 ET
Allergan IncCorporate Event Announcement Notice (WSH)

2014-12-20@20:55:58 ET
Allergan IncCorporate Event Announcement Notice (WSH)

2014-12-20@07:10:23 ET
Merck Up on OncoEthix Acquisition Deal, Oncology in Focus (ZAX)

2014-12-19@20:45:43 ET
Allergan IncCorporate Event Announcement Notice (WSH)

2014-12-19@13:27:11 ET
Next Resistance Level for Allergan (AGN) is $215.84 (F79)

2014-12-19@09:05:33 ET
Allergan (AGN) Showing Resistance Near $215.84 (FBM)

2014-12-19@06:09:24 ET
Acne Vulgaris - Pipeline Review, H2 2014 (MTO)

2014-12-18@17:48:29 ET
AGN SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Involving Allergan, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of February 16, 2015 -- AGN (PMZ)

2014-12-18@15:59:17 ET
EQUITY ALERT: The Rosen Law Firm Announces the Filing of Securities Class Action on Behalf of Sellers of Allergan Inc. Stock From February 25, 2014 to April 21, 2014 Seeking to Recover Losses -- AGN (PMZ)

2014-12-18@15:02:22 ET
Allergan (AGN) Showing Bullish Technicals With Resistance At $210.54 (FBM)

2014-12-18@12:47:13 ET
Allergan Bullish Moving Average Crossover Alert (AGN) (F78)

2014-12-18@06:04:10 ET
Germany Bariatric Surgery Devices Market Outlook to 2020: Key players covered include Covidien, Ethicon Endosurgery and Allergan (MTO)

2014-12-18@04:53:16 ET
Postherpetic Neuralgia - Pipeline Review, H1 2014 (MTO)

2014-12-17@11:15:05 ET
Deadline in Lawsuit for Certain Sellers of Allergan, Inc. (AGN) Shares Announced by Shareholders Foundation (PMZ)

2014-12-17@09:30:00 ET
BOTTINI & BOTTINI, INC. Files Class Action Lawsuit On Behalf Of Persons Who Sold Allergan Stock Between February 25, 2014 And April 21, 2014 (PRN)

2014-12-17@09:05:00 ET
Pharma Equities Technical Analysis -- GlaxoSmithKline, Bristol-Myers Squibb, Teva Pharmaceutical Industries, Endo Intl., and Allergan (PRN)

2014-12-17@08:18:35 ET
Allergan (AGN) Showing Resistance Near $210.08 (FBM)

2014-12-17@08:09:03 ET
Merrimack Pharmaceuticals Announces the Addition of Russell T. Ray to Its Board of Directors (PMZ)

2014-12-16@15:10:54 ET
Allergan (AGN) Trading Near $207.30 Support Level (FBM)

2014-12-16@10:39:35 ET
Allergan (AGN) Approaches New Downside Target of $207.30 (F79)